• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We're Reading: Taxpayers Spending Millions on Expensive Generic Drugs

Article

What we're reading, December 18, 2015: HHS report finds generic drug prices rising faster than inflation; UnitedHealthcare's real-time drug approval tool; and government overcharged by private Medicare Advantage plans.

A report released by HHS, based on their investigation of rising generic drug prices, has found that taxpayers paid $1.4 billion resulting from increasingly expensive generic drugs. The HHS enquiry was at the behest of Sen. Bernie Sanders (I-VT) and Rep. Elijah Cummings (D-MD). Rising faster than inflation, the drug costs could have saved Medicare over $700 million during 2013 and 2014 if rebates were applied to the generic costs.

UnitedHealthcare is collaborating with providers to offer them a fast-track drug approval process that is almost real-time. AIS Health reports that the approval process will follow the recommendations of the National Comprehensive Cancer Network Clinical Practice Guidelines. The pilot was initiated in May 2014 for providers in Florida, and the current program went live in June for Medicaid as well as commercial members of the company in the states of Florida and Arizona.

Records from CMS reveal that private Medicare Advantage plans continued to overcharge the government millions of dollars, despite officials within CMS drawing attention to this fraud as early as 2008. According to a report by NPR, short staffing resulted in very few financial audits by CMS—just 30 audits per year, which account for only 5% of the total number of Medicare Advantage contracts. The first batch of audits are expected to be completed in 2016, per CMS.

Related Videos
Will Shapiro
Mila Felder, MD, FACEP
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Carrie Kozlowski
Carrie Kozlowski, OT, MBA
Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance (COA) and physician and partner of AO Multispecialty Clinic in Augusta, Georgia.
Carrie Kozlowski, OT, MBA
Dr Lucy Langer
Edward Arrowsmith, MD, MPH
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.